One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Healthcare ➤ Blau Syndrome Market
Blau Syndrome Market

Blau Syndrome Market

Published date: Jan 2022 • Formats:
Request Sample
  • Home ➤ Life Science ➤ Healthcare ➤ Blau Syndrome Market

Global Blau Syndrome Market By Type (Treatment, Diagnosis), By Route of Administration (Oral, Parental), By End-User (Hospitals, Diagnostics Centers, Specialty Clinics), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

  • Published date: Jan 2022
  • Report ID: 74392
  • Number of Pages: 332
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Blau Syndrome Market Introduction:

    Blau syndrome is an inflammatory disorder that primarily affects the skin, joints, and eyes. Signs and symptoms begin in childhood, usually before the age of 4. Granulomatous dermatitis which is a form of skin inflammation is one of the earliest signs of Blau syndrome. This condition causes a persistent rash that involves hard lumps or can be scaly, and is generally felt under the skin; this rash is primarily found on the arms, legs, and torso.

    Arthritis is also common in patients suffering from Blau syndrome and is characterized as the inflammation of the lining of the joints (synovium). Synovitis causes joint pain and swelling. It begins by affecting the joints of the hands, wrists, feet, and then ankles. The worsening of this condition may lead to the involvement of additional joints, thereby restricting movement by decreasing the range of motion of several joints.

    Uveitis causes the inflammation of the middle layer of the eye called the uvea. This condition is common among most Blau syndrome patients. The uvea consists of the iris and its related tissue that underline the sclera. Uveitis causes eye irritation and pain, blurred vision, and photophobia. Blau syndrome majorly occurs due to a single mutation in the nucleotide-binding oligomerization domain containing the 2 (NOD2) gene, which produces proteins responsible for immune responses.

    The global Blau syndrome market is segmented on the basis of – type, route of administration, end-user, and region. Listed below is this market’s segmentation:

    By Type

    • Treatment
    • Diagnosis

    Route of Administration

    • Oral
    • Parental
    • Others

    End-User

    • Hospitals
    • Diagnostics Centers
    • Specialty Clinics
    • Others

    Key Players:

    • Pfizer
    • Janssen Pharmaceuticals Inc.
    • Salix Pharmaceutical
    • Novartis AG
    • Mylan N.V.
    • Himka Pharmaceuticals PLC
    • Oncodesign
    • Amgen Inc.
    • Abbvie Inc.
    • Alkem Labs
    • Accord Healthcare
    • Zydus Pharmaceuticals
    • Centogene AG
    • Teva Pharmaceuticals
    • among others.

    By Region

    • North America
      • The US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Korea
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East and Africa
      • GCC
      • Israel
      • South Africa
      • Rest of MEA

    Market Dynamics–

    Increasing awareness levels concerning Blau syndrome, coupled with the ongoing investments towards the healthcare industry are factors expected to boost the revenue growth prospects for this target market. Unfortunately, lower awareness levels among developing nations, as well as the negative impacts of the ongoing COVID-19 pandemic are factors that are expected to influence this market’s financial trajectory. This pandemic has disrupted various manufacturing processes, the effective distribution and sales of goods, from grocery, produce to medical supplies.

    Various nations imposed respective lockdowns in order to slow-down the further contagion. With increasing vaccination drives being held across various nations, respective lockdowns are gradually being relaxed. Manufacturing and sales activities are said to be back on track in the months to follow. These factors are expected to in turn bolstering the revenue growth of the global Blau syndrome market in the process. Moreover, increasing R&D activities to develop a potential cure for this syndrome is also expected to create lucrative opportunities for market players over the forecast period.

    Competitive Landscape

    Major players in this market are – Pfizer, Janssen Pharmaceuticals Inc., Salix Pharmaceutical, Novartis AG, Mylan N.V., Himka Pharmaceuticals PLC, Oncodesign, Amgen Inc., Abbvie Inc., Alkem Labs, Accord Healthcare, Zydus Pharmaceuticals, Centogene AG, and Teva Pharmaceuticals, among others.

    Key Developments:

    In 2018, Oprphan Biovitrum AB received approvals from the European Commission for Kineret, a monoclonal antibody that is used for the treatments of Blau Syndrome.


    For the Blau Syndrome Market research study, the following years have been considered to estimate the market size:

    Attribute Report Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Blau Syndrome Market
    Blau Syndrome Market
    Published date: Jan 2022 • Formats:
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Pfizer Inc Company Profile
    • Janssen Pharmaceuticals Inc.
    • Salix Pharmaceutical
    • Novartis AG
    • Mylan N.V.
    • Himka Pharmaceuticals PLC
    • Oncodesign
    • Amgen Inc.
    • AbbVie Inc. Company Profile
    • Alkem Labs
    • Accord Healthcare
    • Zydus Pharmaceuticals
    • Centogene AG
    • Teva Pharmaceuticals
    • among others.
  • settingsSettings

Related Reports

  • Arthroscopes System Market

    • ★★★★★
      ★★★★★
    • (40)
  • Metal Cutting Fluid Market

    • ★★★★★
      ★★★★★
    • (61)
  • Permanent Artificial Skin Market

    • ★★★★★
      ★★★★★
    • (23)
  • Pharmaceutical Packaging Machines Market

    • ★★★★★
      ★★★★★
    • (99)
  • Antidiabetic Thiazolidinediones Market

    • ★★★★★
      ★★★★★
    • (72)
  • Glass Door Merchandiser Equipment Market

    • ★★★★★
      ★★★★★
    • (72)

Our Clients

  • Our Clients

Inquiry Before Buying


Blau Syndrome Market
  • 74392
  • Jan 2022
    • ★★★★★
      ★★★★★
    • (96)
  • US $5,999
    US $4,499
  • US $7,999
    US $4,999
  • US $9,999
    US $5,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$4,499
USD / per unit
save 25%
Multi User
$7,999
$4,999
USD / per unit
save 38%
Corporate User
$9,999
$5,499
USD / per unit
save 45%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library
Secured Payment Options
Secured Payment Options

© 2023 Market.Us. All Rights Reserved.